BALANCE_STREET_HEALTH_LIM - Accounts


Company Registration No. 3866963 (England and Wales)
BALANCE STREET HEALTH LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018
PAGES FOR FILING WITH REGISTRAR
BALANCE STREET HEALTH LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 6
BALANCE STREET HEALTH LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 MARCH 2018
31 March 2018
- 1 -
2018
2017
Notes
£
£
£
£
Fixed assets
Property, plant and equipment
3
2,656,100
2,660,706
Current assets
Trade and other receivables
4
336,056
334,430
Cash and cash equivalents
262,483
201,670
598,539
536,100
Current liabilities
5
(155,206)
(151,938)
Net current assets
443,333
384,162
Total assets less current liabilities
3,099,433
3,044,868
Non-current liabilities
6
(1,174,773)
(1,174,773)
Provisions for liabilities
(239,971)
(244,042)
Net assets
1,684,689
1,626,053
Equity
Called up share capital
7
6
6
Revaluation reserve
8
1,446,707
1,446,707
Retained earnings
237,976
179,340
Total equity
1,684,689
1,626,053

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 31 March 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 17 December 2018 and are signed on its behalf by:
Dr R C Burton
Director
Company Registration No. 3866963
BALANCE STREET HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018
- 2 -
1
Accounting policies
Company information

Balance Street Health Limited is a private company limited by shares incorporated in England and Wales. The registered office is Balance Street, Uttoxeter, Staffordshire, ST14 8JG.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover represents the invoiced amount of goods sold and services provided stated net of value added tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Property, plant and equipment

Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided at rates calculated to write off the cost or valuation or valuation less estimated residual value of each asset over its expected useful life, as follows:
Land and buildings Freehold
No depreciation charged
Plant and machinery
15 % reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of non-current assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss.

BALANCE STREET HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
1
Accounting policies
(Continued)
- 3 -

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset in prior years. A reversal of an impairment loss is recognised immediately in profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Trade receivables, loans and other receivables that have fixed or determinable payments that are not quoted in an active market are classified as 'loans and receivables'. Loans and receivables are measured at amortised cost using the effective interest method, less any impairment.

Basic financial liabilities

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

BALANCE STREET HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
1
Accounting policies
(Continued)
- 4 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or non-current assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 6 (2017 - 6).

3
Property, plant and equipment
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost or valuation
At 1 April 2017 and 31 March 2018
2,630,000
53,816
2,683,816
Depreciation and impairment
At 1 April 2017
-
23,110
23,110
Depreciation charged in the year
-
4,606
4,606
At 31 March 2018
-
27,716
27,716
Carrying amount
At 31 March 2018
2,630,000
26,100
2,656,100
At 31 March 2017
2,630,000
30,706
2,660,706

The land and buildings were valued on an open market basis by GVA Grimley Ltd, a firm of independent Valuers in September 2012 on an existing use basis.

 

Deferred tax provision has been made for the timing differences which may arise on disposal, in respect of the revaluation.

BALANCE STREET HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
3
Property, plant and equipment
(Continued)
- 5 -

If revalued assets were stated on an historical cost basis rather than a fair value basis, the total amounts included would have been as follows:

2018
2017
£
£
Cost
1,010,012
1,010,012
Accumulated depreciation
-
-
Carrying value
1,010,012
1,010,012
4
Trade and other receivables
2018
2017
Amounts falling due within one year:
£
£
Trade receivables
314,644
311,717
Other receivables
21,412
22,713
336,056
334,430
5
Current liabilities
2018
2017
£
£
Trade payables
101,381
113,560
Taxation and social security
27,532
32,983
Other payables
26,293
5,395
155,206
151,938
6
Non-current liabilities
2018
2017
£
£
Bank loans and overdrafts
1,174,773
1,174,773
BALANCE STREET HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 6 -
7
Called up share capital
2018
2017
£
£
Ordinary share capital
Issued and fully paid
600 Ordinary shares of 1p each
6
6
6
6
8
Revaluation reserve
2018
2017
£
£
At the beginning and end of the year
1,446,707
1,446,707
2018-03-312017-04-01falseCCH SoftwareCCH Accounts Production 2018.300No description of principal activity17 December 2018Dr P J H TrewinDr R C BurtonDr O P BarronDr D J AthertonDr S K BrookesDr S P WrenDr R C Burton38669632017-04-012018-03-3138669632018-03-3138669632017-03-313866963core:LandBuildings2018-03-313866963core:OtherPropertyPlantEquipment2018-03-313866963core:LandBuildings2017-03-313866963core:OtherPropertyPlantEquipment2017-03-313866963core:CurrentFinancialInstruments2018-03-313866963core:CurrentFinancialInstruments2017-03-313866963core:Non-currentFinancialInstruments2018-03-313866963core:Non-currentFinancialInstruments2017-03-313866963core:ShareCapital2018-03-313866963core:ShareCapital2017-03-313866963core:RevaluationReserve2018-03-313866963core:RevaluationReserve2017-03-313866963core:RetainedEarningsAccumulatedLosses2018-03-313866963core:RetainedEarningsAccumulatedLosses2017-03-313866963core:ShareCapitalOrdinaryShares2018-03-313866963core:ShareCapitalOrdinaryShares2017-03-313866963bus:CompanySecretaryDirector12017-04-012018-03-313866963core:LandBuildingscore:OwnedOrFreeholdAssets2017-04-012018-03-313866963core:PlantMachinery2017-04-012018-03-313866963core:LandBuildings2017-03-313866963core:OtherPropertyPlantEquipment2017-03-3138669632017-03-313866963core:OtherPropertyPlantEquipment2017-04-012018-03-313866963bus:OrdinaryShareClass12017-04-012018-03-313866963bus:OrdinaryShareClass12018-03-313866963bus:PrivateLimitedCompanyLtd2017-04-012018-03-313866963bus:FRS1022017-04-012018-03-313866963bus:AuditExemptWithAccountantsReport2017-04-012018-03-313866963bus:SmallCompaniesRegimeForAccounts2017-04-012018-03-313866963bus:Director12017-04-012018-03-313866963bus:Director22017-04-012018-03-313866963bus:Director32017-04-012018-03-313866963bus:Director42017-04-012018-03-313866963bus:Director52017-04-012018-03-313866963bus:Director62017-04-012018-03-313866963bus:CompanySecretary12017-04-012018-03-313866963bus:FullAccounts2017-04-012018-03-31xbrli:purexbrli:sharesiso4217:GBP